文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

多西环素预防细菌性性传播感染的研究现状

Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.
PubMed 文献 · Clin Infect Dis · 2020-01-01

本文综述了多西环素预防梅毒等细菌性性传播感染的研究现状。两项小型短期随机对照试验发现多西环素预防具有高效性,另有五项临床研究正在进行或开发中。但研究设计、人群、结局和安全措施各异,仍需更稳健的数据来评估疗效、目标人群、社区可接受性、行为风险补偿、剂量方案、长期安全性、抗菌药物耐药性、成本效益和风险获益。

要点

  • 两项小型短期随机对照试验显示多西环素预防细菌性性传播感染高效。
  • 多西环素预防细菌性性传播感染前景可观,但需更稳健数据支持。
  • 需评估目标人群、社区可接受性、行为风险补偿、长期安全性和耐药性。

核心结论

  • 多西环素预防细菌性性传播感染显示出前景,但需要更稳健的数据来指导实践。

研究设计与样本

  • 本文为state-of-the-art综述,国际学术和政府专家于2019年3月会议确定初步探究框架,并辅以聚焦文献检索。

主要发现

  • 两项小型短期随机对照试验发现多西环素预防细菌性性传播感染具有高效性。
  • 另有五项临床研究正在进行或开发中,研究设计、人群、结局和安全措施各异。

局限性

  • 需要更稳健的数据来评估疗效、目标人群、社区可接受性、行为风险补偿、多西环素剂量方案和剂型、长期安全性、抗菌药物耐药性、成本效益和风险获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bacterial sexually transmitted infections (STIs) have been increasing over the past 2 decades in gay, bisexual, and other men who have sex with men. With the widespread use of early human immunodeficiency virus (HIV) treatment, which virtually eliminates transmission risk, and the availability of HIV pre-exposure prophylaxis, there have been attitudinal changes regarding HIV infection with resultant increases in sexual contact and declines in condom use. Doxycycline is used for primary prophylaxis in a number of infectious diseases. We conducted a state-of-the-art review to examine the current state of research, knowledge gaps, and challenges around the use of doxycycline prophylaxis to prevent syphilis and other STIs. International academic and government experts met in March 2019 to frame the initial inquiry, which was supplemented by focused literature searches. Two small short-term randomized controlled trials examining doxycycline prophylaxis found high efficacy. Five additional clinical studies are underway or in development. Studies differed in design, population, outcomes, and safety measures. Doxycycline prophylaxis for bacterial STIs shows promise. Better and more robust data are needed on efficacy; target population; community acceptability; behavioral risk compensation; doxycycline dose, regimen, and formulation; long-term safety; antimicrobial resistance; cost-effectiveness; and risk-benefit.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Grant JS, Stafylis C, Celum C, et al. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections. Clin Infect Dis. 2020. PMID: 31504345. doi:10.1093/cid/ciz866

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。